Eastern and South-Eastern Asia vs Laos: Percentage of bloodstream infection due … methicillin-resistant
Eastern and South-Eastern Asia
41.3%
in 2022
Laos
55.9%
in 2022
Eastern and South-Eastern Asia rank
9th
Laos rank
6th
Percentage of bloodstream infection due … methicillin-resistant over time
- Eastern and South-Eastern Asia
- Laos
How they compare
Laos currently reports 55.9% against 41.3% in Eastern and South-Eastern Asia, a difference of 14.6%.
That makes Laos's figure about 1.4 times Eastern and South-Eastern Asia's.
The two have swapped places 3 times across 6 shared years of data; in 2017 it was Eastern and South-Eastern Asia ahead.
Eastern and South-Eastern Asia ranks 9th and Laos ranks 6th of 15 groups.
Across the 2 decades both report, Eastern and South-Eastern Asia averaged higher in 1 and Laos in 1.
Head to head by decade
| Decade | Eastern and South-Eastern Asia | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 32.9% | 9.0% | 24.0% | Eastern and South-Eastern Asia |
| 2020s | 37.5% | 45.3% | 7.7% | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Eastern and South-Eastern Asia or Laos?
- Laos, at 55.9% against 41.3% in Eastern and South-Eastern Asia as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Eastern and South-Eastern Asia and Laos?
- 14.6%, with Laos ahead.
- How many years of comparable data are there for Eastern and South-Eastern Asia and Laos?
- 6 years are reported by both, from 2017 to 2022.
- How do Eastern and South-Eastern Asia and Laos rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Eastern and South-Eastern Asia ranks 9th and Laos ranks 6th of 15 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.